Atrial Septal Defect Closure Device–Related Infective Endocarditis in a 20-Week Pregnant Woman

Sharma, Neeraj; Weena, Ul; Medamana, John; Mann, Noelle; Strachan, Paul; Chikwe, Joanna; Kort, Smadar

doi:10.1016/j.jaccas.2020.09.057

Cited by 4 publications

(4 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Infection of PFO-CDs or atrial septal defect CDs is rare, with only a handful of case reports in the literature. 2 , 3 Verma and Tobis 4 reviewed 13,736 PFO-CD implantations, of which 38 required removal, and only 1 was attributable to endocarditis.…”

Section: Discussionmentioning

confidence: 99%

Petechial Rash and Glomerulonephritis

et al. 2023

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Petechial Rash and Glomerulonephritis

et al. 2023

View full text Add to dashboard Cite

“…Pregnant women may associate a partially immunocompromised status that increases their risk of developing IE in the context of the presence of comorbidities with prognostic implications on the course of pregnancy or fetal viability. This justifies the continuation of antibiotic therapy beyond the 6-month period indicated by current clinical guidelines [ 48 , 49 ]. The susceptibility of pregnant women to certain infectious diseases or the modulation of their severity is closely related to the placental immune response and its tropism for certain pathogens [ 49 , 50 ].…”

Section: From Pathophysiology To Multidisciplinary Assessmentmentioning

confidence: 99%

Infective Endocarditis during Pregnancy—Keep It Safe and Simple!

et al. 2023

View full text Add to dashboard Cite

The diagnosis of infective endocarditis (IE) during pregnancy is accompanied by a poor prognosis for both mother and fetus in the absence of prompt management by multidisciplinary teams. We searched the electronic databases of PubMed, MEDLINE and EMBASE for clinical studies addressing the management of infective endocarditis during pregnancy, with the aim of realizing a literature review ranging from risk factors to diagnostic investigations to optimal therapeutic management for mother and fetus alike. The presence of previous cardiovascular pathologies such as rheumatic heart disease, congenital heart disease, prosthetic valves, hemodialysis, intravenous catheters or immunosuppression are the main risk factors predisposing patients to IE during pregnancy. The identification of modern risk factors such as intracardiac devices and intravenous drug administration as well as genetic diagnostic methods such as cell-free deoxyribonucleic acid (DNA) next-generation sequencing require that these cases be addressed in multidisciplinary teams. Guiding treatment to eradicate infection and protect the fetus simultaneously creates challenges for cardiologists and gynecologists alike.

show abstract

“…The device was removed, the defect was surgically repaired, and no other complications occurred. In addition, patients received prolonged antibiotic treatment (Figure 8) [69][70][71][72][73].…”

Section: Transcatheter Valve Implantation and Other Interventional Pr...mentioning

confidence: 99%

Infective Endocarditis among Pediatric Patients with Prosthetic Valves and Cardiac Devices: A Review and Update of Recent Emerging Diagnostic and Management Strategies

Cinteză

Vasile

et al. 2023

JCM

View full text Add to dashboard Cite

Infective endocarditis (IE) is a disease of the endocardium, which leads to the appearance of vegetation on the valves, cardiac structures, or, potentially, vascular endothelium of the heart. The risk of IE can be increased more than 140 times by congenital heart disease (50–59% of all IE), particularly if cyanotic. An increase in mortality may result from IE in patients with a complex cardiac pathology or patients with an implanted prosthetic material, most frequently conduits in a pulmonary position. Cardiac implantable electronic devices (CIED) infective endocarditis is a life-threatening complication representing 10% of all cases of endocarditis. Common signs of presentation are often fever and chills; redness and swelling at the pocket of the pacemaker, including the erosion and exteriorization of the device; and life-threatening sepsis. The use of intracardiac echocardiography for the diagnosis of IE is an innovative method. This may be needed, especially in older children undergoing complex cardiac surgery, when transthoracic echocardiography (TTE) and transesophageal echocardiography (TOE) failed to provide a reliable diagnosis. The 2018 European Heart Rhythm Association (EHRA) experts’ consensus statement on transvenous lead extraction recommends complete device removal and antimicrobial therapy for any device-related infection, including CIED-IE. The most detected microorganism was Staphylococcus Aureus. In addition, cardiac surgery and interventional cardiology associated with the placement of prostheses or conduits may increase the risk of IE up to 1.6% for Melody valve implantation. Our manuscript presents a comprehensive review of infective endocarditis associated with cardiac devices and prostheses in the pediatric population, including recent advances in diagnosis and management.

show abstract

Atrial Septal Defect Closure Device–Related Infective Endocarditis in a 20-Week Pregnant Woman

Cited by 4 publications

References 11 publications

Petechial Rash and Glomerulonephritis

Petechial Rash and Glomerulonephritis

Infective Endocarditis during Pregnancy—Keep It Safe and Simple!

Infective Endocarditis among Pediatric Patients with Prosthetic Valves and Cardiac Devices: A Review and Update of Recent Emerging Diagnostic and Management Strategies

Contact Info

Product

Resources

About